Gérard Soula
Founder presso ADOCIA
Patrimonio netto: 10 M $ in data 31/03/2024
Profilo
Gérard Soula is the founder.
He founded Flamel Technologies SA in 1990, where he held the title of Chairman & Chief Executive Officer from 1990 to 2005.
He also founded Adocia SA in 2005 and currently serves as Chairman.
Dr. Soula's current job is as a Director at Glowbl SAS.
His former positions include being a Director at Veloxis Pharmaceuticals A and Life Cycle Pharma A.
Dr. Soula obtained a doctorate degree from Université d'Aix-Marseille.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ADOCIA SA
7.14% | 31/12/2022 | 1 006 455 ( 7.14% ) | 10 M $ | 31/03/2024 |
Posizioni attive di Gérard Soula
| Società | Posizione | Inizio |
|---|---|---|
| ADOCIA | Founder | 16/12/2005 |
GLOWBL SAS
 GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Director/Board Member | - |
Precedenti posizioni note di Gérard Soula
| Società | Posizione | Fine |
|---|---|---|
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Founder | 01/01/2005 |
| Life Cycle Pharma A/S | Director/Board Member | - |
| VELOXIS PHARMACEUTICALS A/S | Director/Board Member | - |
Formazione di Gérard Soula
| Université d'Aix-Marseille | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ADOCIA | Health Technology |
| Aziende private | 4 |
|---|---|
Flamel Technologies SA
Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
Veloxis Pharmaceuticals A/S
 Veloxis Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark. | Health Technology |
| Life Cycle Pharma A/S | |
GLOWBL SAS
GLOWBL SAS Packaged SoftwareTechnology Services GLOWBL SAS designs and develops communications software for videoconferencing and content sharing. It enables users to share media content and live events. The company was founded in 2011 and is headquartered in Lyon, France. | Technology Services |
- Borsa valori
- Insiders
- Gérard Soula
